These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 16881247)

  • 21. Psychiatric comorbidity among substance misusing mothers.
    Strengell P; Väisänen I; Joukamaa M; Luukkaala T; Seppä K
    Nord J Psychiatry; 2015 May; 69(4):315-21. PubMed ID: 25426622
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A brief mental health and substance abuse screener for persons with HIV.
    Whetten K; Reif S; Swartz M; Stevens R; Ostermann J; Hanisch L; Eron JJ
    AIDS Patient Care STDS; 2005 Feb; 19(2):89-99. PubMed ID: 15716640
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Screening of psychopathology with juvenile deviants].
    Gutschner D; Völkl-Kernstock S; Perret A; Doreleijers T; Vermeiren R; Fegert JM; Schmeck K
    Neuropsychiatr; 2011; 25(1):26-35. PubMed ID: 21486541
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnosing comorbidity in substance abusers. Computer assessment and clinical validation.
    Ross HE; Swinson R; Larkin EJ; Doumani S
    J Nerv Ment Dis; 1994 Oct; 182(10):556-63. PubMed ID: 7931203
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical rating scales for substance abuse.
    Galletly C
    Psychiatr Serv; 1997 Jan; 48(1):105-6. PubMed ID: 9117490
    [No Abstract]   [Full Text] [Related]  

  • 26. Prevalence of co-occurring disorders among juveniles committed to detention centers.
    Abrantes AM; Hoffmann NG; Anton R
    Int J Offender Ther Comp Criminol; 2005 Apr; 49(2):179-93. PubMed ID: 15746269
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Validity of the SCID in substance abuse patients.
    Kranzler HR; Kadden RM; Babor TF; Tennen H; Rounsaville BJ
    Addiction; 1996 Jun; 91(6):859-68. PubMed ID: 8696248
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A downscaled practical measure of mood lability as a screening tool for bipolar II.
    Benazzi F; Akiskal HS
    J Affect Disord; 2005 Feb; 84(2-3):225-32. PubMed ID: 15708420
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Subtyping study of a pathological gamblers sample.
    Alvarez-Moya EM; Jiménez-Murcia S; Aymamí MN; Gómez-Peña M; Granero R; Santamaría J; Menchón JM; Fernández-Aranda F
    Can J Psychiatry; 2010 Aug; 55(8):498-506. PubMed ID: 20723277
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Screening for social fears and social anxiety disorder in psychiatric outpatients.
    Dalrymple KL; Zimmerman M
    Compr Psychiatry; 2008; 49(4):399-406. PubMed ID: 18555062
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Time patterns of attempted suicide.
    Valtonen H; Suominen K; Partonen T; Ostamo A; Lönnqvist J
    J Affect Disord; 2006 Feb; 90(2-3):201-7. PubMed ID: 16412521
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Age and gender: confounders for axis I disorders as risk factors for suicide].
    Schneider B; Bartusch B; Schnabel A; Fritze J
    Psychiatr Prax; 2005 May; 32(4):185-94. PubMed ID: 15852211
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Discriminant efficiency of antisocial and borderline personality disorder criteria in Hispanic men with substance use disorders.
    Becker DF; Grilo CM; Anez LM; Paris M; McGlashan TH
    Compr Psychiatry; 2005; 46(2):140-6. PubMed ID: 15723032
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Factor structure and diagnostic efficiency of the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, criteria for avoidant personality disorder in Hispanic men and women with substance use disorders.
    Becker DF; Añez LM; Paris M; Bedregal L; Grilo CM
    Compr Psychiatry; 2009; 50(5):463-70. PubMed ID: 19683617
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diagnosing comorbidity in substance abusers: a comparison of the test-retest reliability of two interviews.
    Ross HE; Swinson R; Doumani S; Larkin EJ
    Am J Drug Alcohol Abuse; 1995 May; 21(2):167-85. PubMed ID: 7639204
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dual diagnosis screening interview to identify psychiatric comorbidity in substance users: development and validation of a brief instrument.
    Mestre-Pintó JI; Domingo-Salvany A; Martín-Santos R; Torrens M;
    Eur Addict Res; 2014; 20(1):41-8. PubMed ID: 23921461
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence and profile of people with co-occurring mental and substance use disorders within a comprehensive mental health system.
    Rush B; Koegl CJ
    Can J Psychiatry; 2008 Dec; 53(12):810-21. PubMed ID: 19087479
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Screening and assessing adolescent substance use disorders in clinical populations.
    Winters KC; Kaminer Y
    J Am Acad Child Adolesc Psychiatry; 2008 Jul; 47(7):740-4. PubMed ID: 18574399
    [No Abstract]   [Full Text] [Related]  

  • 39. A tale of two systems: co-occurring mental health and substance abuse disorders treatment for adolescents.
    Hawkins EH
    Annu Rev Psychol; 2009; 60():197-227. PubMed ID: 19035824
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Validity of the Swedish SCID and ADDIS diagnostic interviews for substance use disorders: sensitivity and specificity compared with a LEAD golden standard.
    Gerdner A; Kestenberg J; Edvinsson M
    Nord J Psychiatry; 2015 Jan; 69(1):48-56. PubMed ID: 25298163
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.